|
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation |
Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur-Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Brown T, Pilkington G, Bagust A, Boland A, Oyee J, Tudur-Smith C, Blundell M, Lai M, Martin Saborido C, Greenhalgh J, Dundar Y, Dickson R. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation. Health Technology Assessment 2013; 17(31) Original Paper URL http//journalslibrary.nihr.ac.uk/hta/hta17310 Indexing Status Subject indexing assigned by NLM MeSH Antineoplastic Combined Chemotherapy Protocols /economics /therapeutic use; Carcinoma, Non-Small-Cell Lung /drug therapy /pathology; Carcinoma, Squamous Cell /pathology; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Lung Neoplasms /drug therapy /pathology; Neoplasm Metastasis; Quality-Adjusted Life Years; Receptor, Epidermal Growth Factor /genetics AccessionNumber 22013052625 Date bibliographic record published 13/12/2013 |
|
|
|